Robert F. Kennedy Jr. has been a vocal critic of the pharma trade. He’s stated it’s corrupted U.S. well being businesses and has attacked, typically with false arguments, merchandise from vaccines to weight problems medicines.
So when President-elect Trump, who stated Thursday that drug corporations have “crushed” Individuals, introduced RFK Jr. as his decide for well being secretary, the trade’s share costs dove.
However at an investor convention Tuesday, pharma executives who had been requested in regards to the prospect of an RFK Jr.-led Well being and Human Providers Division sought to undertaking it was enterprise as traditional.
“I’ve been on this trade for 25 years, and it doesn’t matter whether or not it was Clinton speaking about well being care and even by means of after we talked about Obamacare, each administration, there’s been a well being care issue,” David Elkins, the chief monetary official of Bristol Myers Squibb, stated on the Jefferies London Healthcare Convention in London.
This text is unique to STAT+ subscribers
Unlock this text — plus every day protection and evaluation of the pharma trade — by subscribing to STAT+.
Have already got an account? Log in
To learn the remainder of this story subscribe to STAT+.